This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Sortilin regulates sorting and secretion of Sonic hedgehog.
Journal of cell science · 2016
Expression profiles of elastase1 (NvElastaseI) and secretory leukocyte protease inhibitor (NvSLPI) during forelimb regeneration in adult Notophthalmus viridescens suggest a role in epithelial remodeling and delamination.
Development genes and evolution · 2006
Newt orthologue of Growth arrest-specific 6 (NvGas6) is implicated in stress response during newt forelimb regeneration.
Developmental dynamics : an official publication of the American Association of Anatomists · 2006 · first author
Latest funding
- $1,181,926
Unlocking T cell therapy for pediatric brain tumors
CIHR · 2026 · Nominated PI
- $1,178,100
Small molecule enhancement of immune cell function to drive anti-cancer responses
CIHR · 2026 · Nominated PI
- $500,000
Canada Research Chair - Tier 2
CIHR · 2025 · Nominated PI
4 publications.
Sortilin regulates sorting and secretion of Sonic hedgehog.
Campbell C, Beug S, Nickerson PE, Peng J, Mazerolle C, Bassett EA, Ringuette R, Jama FA, Morales C, Christ A, Wallace VA
Expression profiles of elastase1 (NvElastaseI) and secretory leukocyte protease inhibitor (NvSLPI) during forelimb regeneration in adult Notophthalmus viridescens suggest a role in epithelial remodeling and delamination.
Vascotto SG, Beug S, Liversage RA, Tsilfidis C
Newt orthologue of Growth arrest-specific 6 (NvGas6) is implicated in stress response during newt forelimb regeneration.
Beug S, Vascotto SG, Tsilfidis C
Identification of cDNAs associated with late dedifferentiation in adult newt forelimb regeneration.
Vascotto SG, Beug S, Liversage RA, Tsilfidis C
Unlocking T cell therapy for pediatric brain tumors
Principal investigators: Beug, Shawn T
Keywords: Adoptive Cell Therapy; Glioma; Iap Antagonists; Inhibitor Of Apoptosis; Pediatric Brain Tumor; Tumor Infiltrating Lymphocyte
Small molecule enhancement of immune cell function to drive anti-cancer responses
Principal investigators: Beug, Shawn T
Keywords: Breast Cancer; Cancer Cell Death; Smac Mimetics; Tumor Infiltrating Lymphoctes; Tumor Microenvironment
Canada Research Chair - Tier 2
Principal investigators: Beug, Shawn T
Keywords: Crc
Elucidating the immunomodulatory properties of small extracellular vesicles derived from SMAC mimetic treated cancer and immune cells
Principal investigators: Yin, Jordan J
Keywords: Animal Work; Cancer; Cell Culture; Exosomes; Flow Cytometry; Immune System; Immunotherapy; Nanoparticle Tracking Analysis; Small Extracellular Vesicles; Western Blot
Development of Reovirus-based, orally administered, colon cancer vaccines.
Principal investigators: Alain, Tommy
Keywords: Colon Cancer; Mouse Models; Oncolytic Viruses; Orally Administered; Polyps And Pre-Malignant Lesions; Prevention; Recombinant Viruses; Reovirus; Reverse Genetics; Tumour Antigens
Development of an Oral Reovirus-Based Vaccination Platform for COVID-19.
Principal investigators: Alain, Tommy
Targeted immunotherapy for the treatment of brain cancer
Principal investigators: Beug, Shawn T
Keywords: Biomarkers; Cancer; Glioblastoma; Immune Checkpoint Inhibitor; Immunotherapy; Inhibitors Of Apoptosis (Iap); Programmed Cell Death 1 (Pd-1); Smac Mimetic Compound (Smc)
Targeted immunotherapy for the treatment of brain cancer
Principal investigators: Beug, Shawn T
Keywords: Biomarkers; Cancer; Glioblastoma; Immune Checkpoint Inhibitor; Immunotherapy; Inhibitors Of Apoptosis (Iap); Programmed Cell Death 1 (Pd-1); Smac Mimetic Compound (Smc)
Canada Research Chairs - Tier 2
Principal investigators: Beug, Shawn T
Keywords: Crc
Combination immunotherapy for pediatric brain cancer
Principal investigators: Beug, Shawn T
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.